1. Home
  2. DSY vs PASG Comparison

DSY vs PASG Comparison

Compare DSY & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DSY

Big Tree Cloud Holdings Limited Ordinary Shares

HOLD

Current Price

$3.11

Market Cap

28.5M

Sector

N/A

ML Signal

HOLD

PASG

Passage Bio Inc.

HOLD

Current Price

$8.20

Market Cap

28.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSY
PASG
Founded
2020
2017
Country
China
United States
Employees
N/A
27
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.5M
28.3M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
DSY
PASG
Price
$3.11
$8.20
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$34.50
AVG Volume (30 Days)
105.9K
28.3K
Earning Date
01-01-0001
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.48
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.28
52 Week High
$4.01
$20.00

Technical Indicators

Market Signals
Indicator
DSY
PASG
Relative Strength Index (RSI) 79.20 38.43
Support Level $0.33 $8.10
Resistance Level $4.01 $8.85
Average True Range (ATR) 0.19 0.79
MACD 0.26 0.07
Stochastic Oscillator 75.52 14.68

Price Performance

Historical Comparison
DSY
PASG

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, distribution, and sales of personal care products and other consumer goods. Operating under a consumer-to-manufacturer and merchant (C2M) model, the company integrates online and offline operations to enhance customer engagement, product innovation, and marketing efficiency. Specializing in feminine hygiene products such as sterilized feminine pads, menstrual pants, and related items, Big Tree Cloud leverages its platform to consolidate resources within China's personal care industry while building a consumer community that provides direct feedback and product insights.

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

Share on Social Networks: